Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tonix Pharmaceuticals Holding (TNXP) Accounts Payables: 2023-2025

Historic Accounts Payables for Tonix Pharmaceuticals Holding (TNXP) over the last 3 years, with Sep 2025 value amounting to $12.3 million.

  • Tonix Pharmaceuticals Holding's Accounts Payables rose 51.29% to $12.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.3 million, marking a year-over-year increase of 51.29%. This contributed to the annual value of $10.7 million for FY2024, which is 14.54% down from last year.
  • Tonix Pharmaceuticals Holding's Accounts Payables amounted to $12.3 million in Q3 2025, which was up 11.27% from $11.1 million recorded in Q2 2025.
  • In the past 5 years, Tonix Pharmaceuticals Holding's Accounts Payables ranged from a high of $12.5 million in Q4 2023 and a low of $7.7 million during Q1 2025.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's median Accounts Payables value was $10.4 million (recorded in 2024), while the average stood at $10.1 million.
  • Over the last 5 years, Tonix Pharmaceuticals Holding's Accounts Payables had its largest YoY gain of 51.29% in 2025, and its largest YoY loss of 28.09% in 2025.
  • Over the past 3 years, Tonix Pharmaceuticals Holding's Accounts Payables (Quarterly) stood at $12.5 million in 2023, then declined by 14.54% to $10.7 million in 2024, then spiked by 51.29% to $12.3 million in 2025.
  • Its last three reported values are $12.3 million in Q3 2025, $11.1 million for Q2 2025, and $7.7 million during Q1 2025.